Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations. [electronic resource]
Producer: 20180521Description: 1039-1048 p. digitalISSN:- 1549-490X
- Aminopyridines -- pharmacology
- Benzimidazoles -- pharmacology
- Breast Neoplasms -- drug therapy
- Cell Cycle -- drug effects
- Clinical Trials as Topic
- Cyclin-Dependent Kinase 4 -- antagonists & inhibitors
- Cyclin-Dependent Kinase 6 -- antagonists & inhibitors
- Drug Interactions
- Female
- Humans
- Molecular Targeted Therapy -- adverse effects
- Neutropenia -- chemically induced
- Piperazines -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Purines -- pharmacology
- Pyridines -- pharmacology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.